Precision Nephrology: Genetics, Biomarkers, and Diagnostic Labels

Student Handouts and Nephrology Primer · Visual teaching summary · October 3, 2026

Andrew Bland, MD, FACP, FAAP

Visual summary

Order a test when its result could change diagnosis, family counseling, donor assessment, or treatment.

A test result needs phenotype and interpretation. See the diagram description and full text below.
· Download full-size illustration (PNG) · Download Markdown · Read text version ·

Illustration updated October 18, 2026. Educational schematic. Imaging and microscopy panels are illustrations, not patient studies. Full teaching text and sources follow.

Diagram description

A test result needs phenotype and interpretation. Clinical phenotype — Family history and specific kidney findings; Targeted testing — Choose the test for the clinical question; Variant interpretation — Causality and uncertainty require assessment; Actionable care — Counseling, treatment or family implications. A variant or prediction score is not automatically a diagnosis or a treatment instruction. The infographic uses anatomical illustrations and integrated labels; the complete teaching text and evidence are below.

Text version

Recognize a genetic clue

Early onset, affected relatives, kidney disease with hearing/eye findings, cysts, congenital anomalies, or unexplained CKD should prompt consideration of genetic evaluation. A negative family history does not exclude a de novo or recessive disorder.

Connect phenotype to the question

Hematuria plus hearing findings suggests a basement-membrane disorder; cystic kidneys raise a different gene set. Specify the suspected phenotype before choosing a panel, exome, or targeted test with appropriate counseling.

A variant is not automatically causal

A pathogenic/likely pathogenic result must fit the phenotype and inheritance. A variant of uncertain significance should not alone determine irreversible treatment or label relatives affected. Arrange specialist interpretation and possible future reclassification.

Recheck the hypertension label

Heavy proteinuria, active sediment, rapid progression, or a strong family history is not explained simply by coexisting high BP. Investigate another kidney disease before declaring “hypertensive nephropathy.”

Evaluate a prediction tool before use

Check its intended population, calibration, external validation, and the action linked to its output. A high discrimination score in a development cohort does not show benefit or fairness in your clinic.

Worked example

A young adult with unexplained CKD and an affected parent is considering a related living donor. Genetic evaluation may clarify both diagnosis and donor risk; discuss consent and family implications before testing.

Continue learning